Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.49B |
| 2 |
NVIDIA
NVDA
|
+$2.19B |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.94B |
| 4 |
TSMC
TSM
|
+$728M |
| 5 |
UnitedHealth
UNH
|
+$705M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$775M |
| 2 |
AbbVie
ABBV
|
+$540M |
| 3 |
Delta Air Lines
DAL
|
+$434M |
| 4 |
Eli Lilly
LLY
|
+$433M |
| 5 |
DexCom
DXCM
|
+$433M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.89% |
| 2 | Healthcare | 2.92% |
| 3 | Financials | 2.71% |
| 4 | Consumer Discretionary | 2.52% |
| 5 | Industrials | 2.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5251
Invesco S&P 500 Low Volatility ETF
SPLV
$7.21B
| $2.81M | ﹤0.01% |
39,408
-18,748
| -32% | -$1.35M |
|
5252
PUT
Richtech Robotics
RR
$349M
| $2.81M | ﹤0.01% |
871,300
+153,200
| +21% | +$677K |
|
|
AEVA
5253
PUT
Aeva Technologies
AEVA
$1.37B
| $2.81M | ﹤0.01% |
211,700
-132,000
| -38% | -$1.88M |
|
|
DFTX
5254
Definium Therapeutics
DFTX
$5.73B
| $2.81M | ﹤0.01% |
209,944
-129,494
| -38% | -$1.6M |
|
|
UNHG
5255
CALL
Leverage Shares 2X Long UNH Daily ETF
UNHG
$78M
| $2.81M | ﹤0.01% |
167,300
-60,200
| -26% | -$1.2M |
|
5256
ProShares UltraShort Dow 30
DXD
$37.5M
| $2.81M | ﹤0.01% |
+136,994
| New | +$2.92M |
|
5257
PUT
Vanguard Morningstar Value ETF
VTV
$191B
| $2.81M | ﹤0.01% |
14,700
+9,400
| +177% | +$1.77M |
|
5258
Enerpac Tool Group
EPAC
$1.89B
| $2.81M | ﹤0.01% |
73,394
-1,196
| -2% | -$47.4K |
|
5259
ProShares UltraPro Short Dow 30
SDOW
$134M
| $2.8M | ﹤0.01% |
+87,701
| New | +$2.98M |
|
5260
Daktronics
DAKT
$1.05B
| $2.8M | ﹤0.01% |
141,610
+70,335
| +99% | +$1.34M |
|
|
PRMB
5261
PUT
Primo Brands
PRMB
$9.38B
| $2.8M | ﹤0.01% |
171,200
+4,300
| +3% | +$79.5K |
|
5262
E.W. Scripps
SSP
$255M
| $2.8M | ﹤0.01% |
701,157
-188,731
| -21% | -$635K |
|
5263
PUT
WD-40
WDFC
$3.16B
| $2.8M | ﹤0.01% |
14,200
-10,600
| -43% | -$2.09M |
|
5264
iShares AAA-A Rated Corporate Bond ETF
QLTA
$1.23B
| $2.79M | ﹤0.01% |
+58,102
| New | +$2.81M |
|
5265
CALL
iShares Russell Mid-Cap Growth ETF
IWP
$20.6B
| $2.79M | ﹤0.01% |
20,400
-4,900
| -19% | -$685K |
|
5266
Cass Information Systems
CASS
$732M
| $2.79M | ﹤0.01% |
67,260
+53,160
| +377% | +$2.16M |
|
5267
PUT
Darling Ingredients
DAR
$9.31B
| $2.79M | ﹤0.01% |
77,500
-61,100
| -44% | -$2.07M |
|
5268
PUT
USA Compression Partners
USAC
$3.73B
| $2.79M | ﹤0.01% |
121,300
+78,500
| +183% | +$1.84M |
|
5269
PUT
iShares MSCI Taiwan ETF
EWT
$10.6B
| $2.79M | ﹤0.01% |
43,900
-35,600
| -45% | -$2.29M |
|
5270
CALL
Bio-Techne
TECH
$11.2B
| $2.79M | ﹤0.01% |
47,400
-22,300
| -32% | -$1.35M |
|
5271
Winmark
WINA
$1.27B
| $2.79M | ﹤0.01% |
6,879
+58
| +0.9% | +$24.8K |
|
5272
PUT
Flowserve
FLS
$10.1B
| $2.78M | ﹤0.01% |
40,100
-3,200
| -7% | -$206K |
|
|
DBVT
5273
DBV Technologies
DBVT
$841M
| $2.78M | ﹤0.01% |
145,129
+123,080
| +558% | +$1.92M |
|
5274
National Health Investors
NHI
$3.63B
| $2.78M | ﹤0.01% |
36,418
+24,248
| +199% | +$1.86M |
|
|
FITB
5275
PUT
Fifth Third Bancorp
FITB
$52.5B
| $2.78M | ﹤0.01% |
59,400
-58,800
| -50% | -$2.59M |
|
Similar funds
Citadel Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Citadel Advisors held 14,701 positions worth $666B, up 1.3% from $657B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q4 2025 filing shows 2,078 new, 5,000 increased, 5,363 reduced and 2,191 closed positions. Its largest new stake was Medline Inc: 6,006,339 shares worth $252M. The largest sale was Meta Platforms (Facebook), an estimated $775M.
By sector, the portfolio is most concentrated in Technology at 4.9% of assets, up from 3.8% a quarter earlier, followed by Healthcare and Financials.
- Citadel Advisors's largest Q4 2025 buy was Medline Inc: 6,006,339 shares worth $252M.
- Citadel Advisors added most to Amazon in Q4 2025, an estimated $2.49B increase.
- Citadel Advisors's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $775M.
- Citadel Advisors fully exited WEX in Q4 2025, selling an estimated $131M.
- Citadel Advisors's ten largest holdings make up 23% of its $666B portfolio in Q4 2025.
- Citadel Advisors opened 2,078 new positions and closed 2,191 in Q4 2025.
- Citadel Advisors's portfolio value rose 1.3% quarter-over-quarter to $666B.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.